Patent Assignment
Reel/Frame 040293/0249
Change of Address
Recorded: 2016-10-03
Pages: 4
Assignor
EGALET LTD.
Executed: 2016-07-13
Assignee
EGALET LTD.
DECHERT LLP, 160 QUEEN VICTORIA STREET, LONDON, EC4V 4QQ, UNITED KINGDOM
Covered Properties
(44)
Controlled Release Composition
Patent:
6,787,156 →
Application:
08/693,254 →
Controlled release composition
Application:
09/647,590 →
Morphine polymer release system
Application:
10/490,169 →
Publication:
US 2004/0253310
Controlled release solid dispersions
Application:
10/490,170 →
Publication:
US 2005/0019399
Polymer release system
Application:
10/490,308 →
Publication:
US 2004/0234602
Morphine controlled release system
Matrix Compositions for Controlled Delivery of Drug Substances
Controlled release carvedilol compositions
Application:
10/703,084 →
Publication:
US 2004/0151772
Controlled release composition
Application:
10/827,521 →
Publication:
US 2005/0019405
Controlled Release Composition
Swellable Dosage Form Comprising Gellan Gum
Solid Pharmaceutical Composition with a First Fraction of a Dispersion Medium and a Second Fraction of a Matrix, the Latter Being at Least Partially First Exposed to Gastrointestinal Fluids
Application:
11/915,655 →
Publication:
US 2009/0274759
Controlled release solid dispersions
Application:
12/073,691 →
Publication:
US 2008/0234352
Polymer release system
Controlled release carvedilol compositions
Morphine Polymer Release System
Controlled release composition
Application:
12/213,087 →
Publication:
US 2008/0254124
Pharmaceutical Compositions and Methods for Mitigating Risk of Alcohol Induced Dose Dumping or Drug Abuse
Application:
12/523,045 →
Publication:
US 2010/0291205
Controlled Release Pharmaceutical Compositions for Prolonged Effect
Matrix Compositions for Controlled Delivery of Drug Substances
Application:
12/642,416 →
Publication:
US 2010/0166866
Controlled Release Formulations with Continuous Efficacy
Application:
12/694,197 →
Publication:
US 2010/0203129
Immediate Release Composition Resistant to Abuse by Intake of Alcohol
Pharmaceutical Compositions Resistant to Abuse
Formulations and Methods for the Controlled Release of Active Drug Substances
Swellable Dosage Form Comprising Gellan Gum
Formulations and Methods for the Controlled Release of Active Drug Substances
Formulations and Methods for the Controlled Release of Active Drug Substances
Application:
13/928,190 →
Publication:
US 2013/0287850
Abuse Deterrent Pharmaceutical Compositions for Controlled Release
Morphine Polymer Release System
Polymer Release System
Pharmaceutical Compositions Resistant to Abuse
Abuse-Deterrent Pharmaceutical Compositions for Controlled Release
Controlled Release Pharmaceutical Compositions for Prolonged Effect
Morphine Controlled Release System
Controlled Release Formulations with Continuous Efficacy
Application:
14/560,579 →
Publication:
US 2015/0150812
Immediate Release Composition Resistant to Abuse by Intake of Alcohol
Pharmaceutical Compositions Resistant to Abuse
Morphine Controlled Release System
Immediate Release Composition Resistant to Abuse by Intake of Alcohol
Application:
61/150,577 →
Pharmaceutical Compositions Resistant to Abuse by Chewing
Application:
61/150,620 →
Immediate Release Composition Resistant to Abuse by Intake of Alcohol
Application:
61/151,491 →
Controlled Release Formulations
Application:
61/219,817 →
Abuse Deterrent Pharmaceutical Compositions for Controlled Release
Application:
61/668,741 →
Formulations and Methods for the Controlled Release of Active Drug Substances
Application:
96/000,130 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 19, 2009
From: DOWNIE, KEN; PEDERSEN, ANDERS VAGNO; HAAHR, ANNE-METTE; HEMMINGSEN, PERNILLE HOYRUP
To: EGALET A/S
Reel/Frame 023547/0410 →
Assignment of Assignor's Interest
May 4, 2012
From: ANDERSEN, CHRISTINE; FISCHER, GINA; BAR-SHALOM, DANIEL; SLOT, LILLIAN
To: EGALET A/S
Reel/Frame 028160/0735 →
Security Interest
Aug 31, 2016
From: EGALET CORPORATION; EGALET US, INC.; EGALET LTD
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 039600/0791 →
Corrective Assignment to Correct the Omitted Inventor Previously Recorded at Reel: 019693 Frame: 0031. Assignor(S) Hereby Confirms the Assignment.
Sep 16, 2016
From: BAR-SHALOM, DANIEL; SLOT, LILLIAN; FISCHER, GINA; HEMMINGSEN, PERNILLE HOYRUP
To: EGALET A/S
Reel/Frame 040054/0790 →
Grant of Security Interest in Patents
Mar 20, 2019
From: EGALET CORPORATION; EGALET US, INC.; EGALET LIMITED
To: CANTOR FITZGERALD SECURITIES, AS COLLATERAL AGENT
Reel/Frame 050152/0828 →
Release of Security Interest
Apr 12, 2019
From: CANTOR FITZGERALD SECURITIES, AS AGENT AND AS COLLATERAL AGENT
To: EGALET CORPORATION; EGALET LIMITED; EGALET US, INC.
Reel/Frame 048869/0749 →
Assignment of Assignor's Interest
Jun 18, 2019
From: EGALET LTD
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 049505/0851 →
Release of Security Interest
Sep 13, 2019
From: U.S. BANK NATIONAL ASSOCIATION
To: EGALET CORPORATION; EGALET US, INC.; EGALET LTD
Reel/Frame 050367/0019 →
Release of Security Interest in Patents
May 21, 2020
From: CANTOR FITZGERALD SECURITIES, AS AGENT AND AS COLLATERAL AGENT
To: ZYLA LIFE SCIENCES (F/K/A EGALET CORPORATION); ZYLA LIFE SCIENCES US INC. (F/K/A EGALET US, INC.); EGALET LIMITED
Reel/Frame 052740/0025 →
Release of Security Interest
Aug 5, 2020
From: U.S. BANK NATIONAL ASSOCIATION
To: ZYLA LIFE SCIENCES, F/K/A EGALET CORPORATION; ZYLA LIFE SCIENCES US INC., F/K/A EGALET US, INC.; EGALET LIMITED
Reel/Frame 053411/0496 →
Security Interest
Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →
Security Interest
Nov 8, 2022
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: TEAL MIDCO HOLDINGS, L.P.
Reel/Frame 061698/0541 →